Trials / Unknown
UnknownNCT05270629
Supermicrosurgical Lymphvenous Bypass Intervention for Treatment
Supermicrosurgical Lymphvenous Bypass Intervention for Lymphedema Treatment
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 87 (estimated)
- Sponsor
- Chang Gung Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Background: In addition to antegrade anastomosis, retrograde anastomosis has been thought to offer further improvements after lymphaticovenous anastomosis (LVA) by bypassing the retrograde lymphatic flow. However, this concept has yet to be validated. The aim of this study was to determine the impacts on outcomes of performing both retrograde and antegrade anastomosis, as compared to antegrade-only anastomosis for treating lower limb lymphedema.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Antegrade and retrograde anastomoses | Patients who had received both antegrade and retrograde anastomoses. |
| OTHER | Antegrade-only anastomoses | Patients who had received antegrade-only anastomoses. |
Timeline
- Start date
- 2021-09-06
- Primary completion
- 2022-08-31
- Completion
- 2022-09-05
- First posted
- 2022-03-08
- Last updated
- 2022-03-08
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05270629. Inclusion in this directory is not an endorsement.